Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion

This comprehensive review examines the unique attributes, distinctions, and clinical implications of ceftazidime–avibactam (CAZ-AVI) and meropenem–vaborbactam (MEM-VAB) against difficult-to-treat <i>Enterobacterales</i> infections. Our manuscript explores these antibiotics’ pharmacokinetic and pharm...

Descripció completa

Dades bibliogràfiques

Autors principals:	Andrea Marino, Edoardo Campanella, Stefano Stracquadanio, Maddalena Calvo, Giuseppe Migliorisi, Alice Nicolosi, Federica Cosentino, Stefano Marletta, Serena Spampinato, Pamela Prestifilippo, Stefania Stefani, Bruno Cacopardo, Giuseppe Nunnari
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2023-10-01
Col·lecció:	Antibiotics
Matèries:	ceftazidime–avibactam meropenem–vaborbactam carbapenem-resistant <i>Enterobacterales</i> carbapenemases Gram-negative infections new BL/BLICs
Accés en línia:	https://www.mdpi.com/2079-6382/12/10/1521
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!